COVACERT, created in 2007 (United States), from
142 sister brands
and 17477 competing brands.
COVACERT is a brand of Amgen, listed on the stock exchange of New York.
COVACERT belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.